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Abstract Periodontitis represents a highly prevalent health
problem, causing severe functional impairment, reduced qual-
ity of life and increased risk of systemic disorders, including
respiratory, cardiovascular and osteoarticular diseases, diabe-
tes and fertility problems. It is a typical example of a multi-
factorial disease, where a polymicrobial infection inducing
chronic inflammation of periodontal tissues is favoured by
environmental factors, life style and genetic background.
Since periodontal pathogens can colonise poorly vascularised
niches, antiseptics and antibiotics are typically associated with
local treatments to manage the defects, with unstable out-
comes especially in early-onset cases. Here, the results of a
retrospective study are reported, evaluating the efficacy of a
protocol (Periodontal Biological Laser-Assisted Therapy,
Perioblast™) by which microbial profiling of periodontal
pockets is used to determine the extent and duration of local
neodymium-doped yttrium aluminium garnet (Nd:YAG) laser
irradiation plus conventional treatment. The protocol was
applied multicentrically on 2683 patients, and found to pro-
duce a significant and enduring improvement of all clinical
and bacteriological parameters, even in aggressive cases.
Microbiome sequencing of selected pockets revealedmajor pop-
ulation shifts after treatment, as well as strains potentially asso-
ciated with periodontitis in the absence of known pathogens.
This study, conducted for the first time on such a large series,
clearly demonstrates long-term efficacy of microbiology-driven
non-invasive treatment of periodontal disease.
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Introduction
Periodontitis is a complex inflammatory multifactorial disease,
caused by the disruption of normal homeostatic processes by
numerous bacterial species present in subgingival dental plaque
[1]. It affects the support structures of the teeth and, if untreated,
may result in pain, impaired mastication and tooth loss [2].
Microcolonies of oral pathogens attach to the tooth surface,
infiltrate periodontal tissues and organise a subgingival plaque
biofilm. Although the microbial infection is the main
aetiological factor, the pathogenesis of periodontitis is a com-
plex interaction between the microbiome, host tissues and indi-
vidual immune response [3], further modified by environmental
factors, age and smoking [4]. In fact, periodontitis occurs when
pathogenic bacterial species begin to dominate, overruling host
defence and triggering an enhanced immune response, which
may persist, leading to dysregulated and non-effective chronic
inflammation [1]. Moreover, there is increasing evidence of a
strong correlation between the presence of pathogenic bacteria
in periodontal lesions and several systemic diseases. In partic-
ular, bacteraemia and systemic endotoxin release can lead to
the onset and progression of respiratory and cardiovascular dis-
eases, rheumatoid arthritis and diabetes mellitus [5].
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Furthermore, oral bacteria can bypass the placenta filter, with a
consequent increase of mediators responsible for infertility, pre-
term births and underweight newborns [6–8]. Traditionally,
periodontitis is considered as a chronic disease, easy to relapse
and without an effective therapy in the aggressive cases, that
represent 10 % of the total [9, 10]. Treatment procedures in-
volve scaling and root planing (SRP), local antiseptic and sys-
temic antibiotic administration, periodontal surgery and, ulti-
mately, extraction of compromised teeth. Indeed, post-therapy
microbial rebound has been demonstrated, as periodontal
pockets may be re-colonised by putative periodontal pathogens
already one week after mechanical debridement [11, 12].
An increased and lasting decontamination of the periodon-
tal pockets and of the oral ecosystem, together with radiolog-
ically detectable bone mineralisation and regeneration, can be
achieved through the use of high-powered neodymium-doped
yttrium aluminium garnet (Nd:YAG) laser [13]. The antimi-
crobial properties of laser allow the deep and lasting decon-
tamination from pathogens and the inactivation of bacterial
endotoxins in periodontal pockets, as well as in root canals
and around implants [14]. Nd:YAG laser overcomes the resis-
tance of subgingival biofilm communities to antibiotics tradi-
tionally used in dental practice and it exerts an antiseptic ac-
tion also in tissues poorly or not vascularised, like bone or
dentin, unreachable by drugs [15]. Moreover, laser irradiation
promotes fibroblasts and osteoblasts activity, likely through
the activation of BMP-2-related signalling pathways, resulting
in an increase of collagen production during the periodontal
healing phase [16–18]. All the above studies, however, have
been conducted on an extremely limited number of cases and
require more extensive validation. The primary aim of this
retrospective study, performed for the first time on 2683 pa-
tients and on 13,550 periodontal pockets, with a long-term
follow-up (24 months), is to provide a statistically robust eval-
uation of the clinical and microbiological efficacy of non-
surgical laser periodontal treatment in conjunction with SRP.
A secondary aim of the study was to reach, through
metagenomics analysis, a deeper characterisation of bacterial
species involved in periodontitis and to highlight novel
candidate periodontal pathogens.
Methods
Detailed information is described in the Supplementary
material.
Generation of the dataset
A series of 2683 periodontal patients, treated by various
clinicians in six different clinics, has been retrospectively
assessed. Patients were anonymised and informed consent
was obtained from all subjects.
Laser irradiation of periodontal pockets
The standard Nd:YAG laser setting parameters were: frequen-
cy 20 Hz, 2Watt, 100 mJoule, 50/100 μs pulse duration. Each
patient underwent at least four sessions of laser treatment until
a stable microbiological shift occurred.
Sample collection
Sampling was carried out following the procedures reported in
the BPA kit (Bacterial Periodontal Assessment, Biomolecular
Diagnostic, Firenze, Italy).
Assessment of periodontopathic bacteria
Plaque samples were sent to Biomolecular Diagnostic (Firen-
ze, Italy). The DNA extraction was performed using
QIAsymphony (QIAGEN), according to the manufacturer’s
protocol. Real-time polymerase chain reaction (PCR) with
SYBR Green assays were carried out using Rotor-Gene Q
(QIAGEN) apparatus to quantify the most important
periodontopathogens, including Porphyromonas gingivalis,
Treponema dent ico la and Tannere l la forsy th ia ,
Peptostreptococcus micros, Fusobacterium nucleatum ssp.
polymorphum, Prevotella intermedia, Campylobacter rectus,
E i k e n e l l a c o r r o d e n s a n d A g g r e g a t i b a c t e r
actinomycetemcomitans.
Statistics
All statistical and distribution analyses were carried out with
Excel (Microsoft). Distributions of the various clinical
(PPD, BOP%, PUS%) and bacteriological (TOT BAC,
RED, ORANGE, GREEN) variables at diagnosis and at
different follow-up times were compared by Student’s t-test.
16S rRNA metagenomics of the microbial community
and NGS raw data processing of samples
The microbial DNA of patients was quantified by the BioPho-
tometer (Eppendorf) and 16S rRNA sequencing was per-
formed using HiSeq 2000 (Illumina). Patterns of microbial
community structure were analysed from the samples collect-
ed. The V4 region of the 16S rRNA gene was PCR amplified
by using the NEXTflex™ 16S V4 Amplicon-Seq Kit (Bioo
Scientific Corporation, Austin, TX, USA) following the man-
ufacturer’s protocol, and the resulting amplicons (∼250 bp
long) were cleaned, quantified and sequenced on the Illumina
MiSeq platform using paired 150-bp reads. Sequences analy-
sis was performed by using the Metagenomics workflow of
MiSeq Reporter v2.3 (Illumina).
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Study approval
Within the manuscript, there are no experiments requiring
appropriate institutional review board(s) approval.
Results
Clinical response: site-level analysis
This retrospective study has been conducted on a consecutive
series of 2683 periodontal patients (Table 1), profiled and
treated according to a protocol (Periodontal Biological
Laser-Assisted Therapy, Perioblast™) based on Nd:YAG la-
ser irradiation of periodontal pockets guided by qualitative
and quantitative assessment of bacterial populations in the
pockets, as illustrated in Supplementary Figure 1. Further de-
tails are provided in the Supplementary material. Periodontal
probing depth (PPD), bleeding on probing (BOP) and suppu-
ration (PUS) were assessed before and after treatment in 13,
550 pockets, for up to 12–24 months (Table 2). The mean
pocket depth was reduced from 6.25 mm before treatment to
4.24 mm after 1–4 months, 4.04 mm after 4–12 months and
3.80 mm after 12–24 months (Fig. 1a). Similarly, BOP-
positive sites decreased from 91 % to around 50 % (Fig. 1b)
and PUS-positive sites decreased from 46 % to around 2 %,
over the same time intervals (Fig. 1c). No differences were
observed when considering gender. PPD reduction was also
analysed in subgroups with different ranges of PPD at diag-
nosis: 4–6 mm, 7–9 mm and>9 mm. Reduction was signifi-
cant at all follow-up times, independently of the extent of PPD
at diagnosis (Fig. 1d), and completely overlapping also in
young patients (<35 years old; n= 1380; Supplementary
material and Supplementary Figure 2).
Bacteriological response
The microbiological status of periodontal pockets was
assessed at diagnosis and after 1–4 months, 4–12 months
and 12–24 months fol lowing treatment (see the
Supplementary material). The average total bacterial load
was drastically reduced, progressively decreasing from 53 to
16 million (T-test p-values: <10−7 at 1–4 months, <10−12 at
4–12 months and <10−16 at 12–24 months). Reduction of
known pathogens was even more marked, from 5.3 million
to 610,000 on average (T-test p-values: <10−8 at 1–4 months,
<10−7 at 4–12 months and 12–24 months; Fig. 2a). Within
pathogens, the distribution of the red, orange and green
Socransky’s complexes [19] was then considered, given their
involvement in different phases of the periodontal disease. In
particular, prevalence of the red complex (P. gingivalis, A.
actinomycetemcomitans, T. denticola, T. forsythia and
P. micros) is associated with advanced periodontitis and
PPD of 6 mm or deeper, while prevalence of the orange com-
plex (F. nucleatum ssp., P. intermedia and C. rectus) is asso-
ciated with either the progression of the disease from mild to
advanced or to its initial regression. Prevalence of the green
complex (E. corrodens) is typically associated with the final
phase of biological healing [20]. Changes in the distributions
of the red, orange and green complexes are shown in Fig. 2b.
The average load of all three complexes decreased drastically,
but the decrease of the red complex was the most striking,
already significant at 1–4 months and lasting until
12–24 months. In accordance with clinical observations, no
significant differences in the response were observed when
considering gender (see the Supplementary material). In the
group of young patients, the average total bacteria load pro-
gressively decreased from 61 to 17 million and the known
pathogens fraction decreased from 3.7 million to 390,000
(Fig. 2c). The lower amount and the distribution of the
pathogens among the three complexes at baseline and after
treatment are illustrated in Fig. 2d.
Metagenomics
In a small fraction of cases (approximately 10 %), known
periodontal pathogens were not detected or their levels were
not high enough to explain the clinical signs and severity of
periodontitis. To explore the presence of bacterial signatures
related to periodontal disease, next-generation sequencing
(NGS)-based microbiome analysis was carried out on the peri-
odontal pockets of 20 cases, subdivided into three groups as
follows. The first group (‘Pretreatment’) included six peri-
odontal patients affected by aggressive periodontitis with the
presence of known pathogens, before any treatment. The sec-
ond group (‘Treated’) was composed of samples taken from
the same patients described above, but after successful
Perioblast™ treatment. Finally, the third group (‘False
Negatives’) included eight samples from patients clinically
affected by advanced periodontal disease (PPD> 6 mm,
BOP and/or PUS), for which the results of microbiological
tests revealed a very low percentage of known pathogens
without the presence of periodontal species belonging to the
red complex, also after repetition of the entire procedure of
sampling and PCR analysis. NGS analysis was performed on
the 16S rRNA gene from DNA extracted and amplified from
Table 1 Demographic characteristics of the 2683 periodontal patients
Age, years (mean ± standard deviation) 49.72 ± 12.1
<35 years old 265 (9.9 %)
Females 1561 (58.2 %)
Smokers 940 (35 %)
Caucasian ethnicity 2683 (100 %)
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subgingival plaque samples as described (details in the
Supplementary material).
First of all, samples were analysed by means of rare-
faction curves [21]. All curves reached an asymptote,
showing that the bacterial diversity was adequately esti-
mated in all samples (Supplementary Figure 3). Taxonom-
ic assignments obtained through NGS analysis were tab-
ulated at the phylum level and used to generate the
barplots reported in Fig. 3a, displaying the relative abun-
dance of the phyla detected in each sample. Clearly, cases
belonging to the same subgroup had a similar community
structure, with major differences between pretreatment
samples and the remaining two subgroups. Particularly,
the elimination of the spirochaetes (orange bars) in the
Treated samples was evident, along with their extremely
low levels in the False Negatives group. Conversely,
proteobacteria were prevalent in both the Treated and
False Negatives groups. Accordingly, ANOSIM [22] and
CCA [23] analyses confirmed that samples of the Pretreat-
ment group tend to form a completely separate cluster,
while clusters formed by the Treated and False Negatives
groups display some degree of overlap (Supplementary
Figure 4). However, significant ANOSIM p-values (less
than 0.01) showed that bacterial communities associated
with different states of periodontal disease have a distinct
taxonomic structure at the phylum level.
Table 2 Summary of the
microbiological and clinical
parameters before and after
treatment
Variable Baseline 1–4 months 4–12 months 12–24 months
N. of analysed patients 2683 2090 634 684
Average total bacteria 53,760,815 29,418,693 20,677,076 16,013,911
Red complex 3,171,051 (58.9 %) 93,122 (14.5 %) 89,690 (18.3 %) 173,404 (28.3 %)
Orange complex 1,758,019 (32.7 %) 237,180 (36.8 %) 243,979 (49.7 %) 389,495 (63.4 %)
Green complex 424,099 (7.9 %) 286,521 (44.5 %) 129,389 (26.3 %) 105,603 (17.2 %)
Average total pathogens 5,379,946 (10 %) 643,851 (2.2 %) 490,960 (2.4 %) 614,128 (3.8 %)
N. of analysed pockets 13,590 9977 3060 3246
Average PPDa 6.25 mm 4.24 mm 4.04 mm 3.80 mm
BOPb 91 % 52 % 49 % 53 %
PUSc 46 % 1 % 1 % 2 %
aPPD periodontal probing depth
bBOP bleeding on probing
cPUS suppuration
Fig. 1 Clinical response: site-
level analysis. a Average peri-
odontal probing depth (PPD) re-
duction on 13,550 pockets with
follow-up at different times. b
Average bleeding on probing
(BOP) reduction and c average
suppuration (PUS) reduction on
the same pockets. d Reduction of
different PPD ranges at different
times in the whole population
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To better characterise the bacterial species involved in peri-
odontal disease, NGS data were analysed at the operational
taxonomic unit (OTU) level. In 2009, Colombo and col-
leagues [24] described a bacterial signature distinguishing pa-
tients with treatment-refractory periodontitis from good re-
sponders and healthy cases. The signature included known
pathogens, such as some red complex bacteria and C. gracilis,
and ‘unusual’ species, including TM7 spp., Bacteroidetes sp.,
Veillonella atypica, Desulfobulbus sp., Brevundimonas
diminuta, Gemella sanguinis, Mogibacterium tidmidum,
Mycoplasma salivarium, Anaeroglobus geminatus,
Megasphaera micronuciformis, Streptococcus parasanguinis,
Pasteurella stomatis, F. naviforme and T. medium. It was,
therefore, verified how these species are represented in our
NGS dataset. As shown in Fig. 3b, red complex bacteria (T.
denticola, T. forsythia and P. gingivalis) were highly abundant
in all Pretreatment samples and were almost ablated in
Treated cases. As expected, they were barely detectable in
the False Negatives group. Interestingly, C. gracilis displayed
a similar pattern of depletion upon treatment, but was also
well represented in some of the samples of the False Negatives
group (Fig. 3c). Among the unusual species, representation of
Filifactor alocis, Bacteroidetes sp. and Desulfobulbus sp. was
substantially overlapping with that of the red complex
(Supplementary Figure 5), while TM7 and Dialister invisus
were reduced by treatment but also clearly detectable in a
fraction of the cases in the False Negatives group (Fig. 3d).
To identify new candidate pathogens in the False Negatives
group, analysis of the similarity percentage (SIMPER analy-
sis) [22] was carried out, comparing each group of samples
with the others, to highlight OTUs with differential represen-
tation. The analysis revealed very clear differences between
Pretreatment samples and either the Treated or False Nega-
tives groups, and lower divergence between samples in the
Fig. 2 Bacteriological response. a Average percentage of pathogens
among total bacteria in 2683 patients with follow-up at 1–4 months and
12–24 months. bDistribution of red, orange and green complexes among
pathogens in the same patients at the same times. cAverage percentage of
pathogens among total bacteria in 265 patients aged <35 years. d Distri-
bution of red, orange and green complexes among pathogens in patients
aged <35 years at the same times
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Treated and False Negatives groups (Supplementary Figure
6). Starting from the 57 OTUs that, according to the SIMPER
analysis, distinguish samples in the False Negatives group
from those in the Treated group, we identified seven OTUs
(Aggregatibacter 3, Porphyromonas 9, Prevotella sp._34,
Leptotrichia sp._22, Cardiobacterium hominis 6,
Selenomonas sp. 12, Actinomyces 5) specifically high in the
False Negatives group and three that were also high in the
Pretreatment samples (Fig. 3e).
Discussion
The present multicentric retrospective study demonstrates that
microbiologically guided Nd:YAG laser irradiation of peri-
odontal pockets, in conjunction with SRP, is an effective treat-
ment for advanced periodontitis. The results of the present
study are comparable to those described by some authors
[25, 26], but better if compared to those reported by literature
meta-analysis studies [27, 28]. Reduction of PPD, BOP and
PUS in response to the treatment protocol was proven to occur
early and last for 24 at least months. A clear tendency for
continuous parameter improvement was observed, which
reflects long-term treatment-induced normalisation of the
periodontal microenvironment, favouring further regression
of the lesions.
Many research groups have examined microbiological
shifts in periodontal pockets after applying conventional
non-surgical periodontal therapy to patients (including SRP
alone or in combination with antibiotics and antiseptics)
[29–37]. In comparison with our study, smaller samples of
patients were used in these studies. Furthermore, periodontal
pockets were re-colonised by measurable amounts of peri-
odontal pathogens as early as 3 months after periodontal ther-
apy. Although supplemental administration of antibiotics and
antiseptics was more beneficial than SRP alone in general,
follow-up for these studies lasted no longer than 12 months
from the initial therapy. That happened because, by that time,
Fig. 3 Metagenomics. a Relative abundances of bacterial phyla detected
in all samples. The colour patterns refer to nine distinct bacterial phyla
and two unclassified ones. Samples were divided into three separated
panels according to their group of patients, reporting the group name at
the top of the panels. b Next-generation sequencing (NGS)-based calcu-
lation of the abundance of red complex bacteria (expressed as the sum of
the reads per million of Treponema denticola, Tannerella forsythia and
Porphyromonas gingivalis) in 20 samples, subdivided into Pretreatment,
Treated and False Negatives groups, as indicated. The same abundance
representation is displayed in c forCampylobacter gracilis and d for TM7
and Dialister invisus, all displaying a marked reduction in Treated cases,
but also well detected in some of the False Negatives group. e Abun-
dance, in terms of reads per million, of ten operational taxonomic units
(OTUs) strongly associated with the False Negatives group. Three of
them are also abundant in Pretreatment samples
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periodontal pathogens levels had increased to the initial levels
before treatment.
The fact that similar results have also been obtained in
young patients is remarkable since, according to the current
literature, periodontitis in young patients is considered aggres-
sive, refractory or shortly responsive to treatments, with a
quick progression of the tissue damage [9, 10]. Considering
the microbiological status of periodontal pockets, the average
total bacterial load was drastically reduced at all follow-up
times, with reduction of known pathogens being even more
evident. These results reflect both improved short-term control
compared to the current literature and unprecedented long-
term control. In particular, among the three Socransky’s com-
plexes [19], the reduction in the red complex was the most
notable, which is particularly relevant, given its association
with advanced phases of periodontitis.
Interestingly, the <35 years old group was characterised by
a significantly lower pathogen load at baseline, despite equal-
ly severe clinical parameters of disease. This suggests a role
for individual genetic susceptibility, allowing a lower patho-
gen load to promote early onset of aggressive periodontitis.
Also, the discrepancy between low pathogen load and clinical
severity could be due to the presence of bacteria not currently
recognised as periodontal pathogens. In this respect, laser
treatment could provide substantial therapeutic benefits when
added to conventional treatment. Indeed, the results obtained
in this group of patients, similar to those obtained in the whole
population, confirm also from the microbiological point of
view the enduring efficacy of the laser therapy protocol, even
in aggressive, early-onset periodontal disease. Studies inves-
tigating the microbiological shifts in periodontal pockets of
patients with aggressive periodontitis after conventional treat-
ment showed similar limitations to the respective studies that
included patients with chronic periodontitis referred above,
compared to our study (small sample, re-colonisation of peri-
odontal pockets by periodontal pathogens after 3 months,
follow-up no longer than 6 months) [38, 39].
In about 10 % of cases, patients negative at diagnosis for
known pathogens, in particular for the Socransky red com-
plex, are clinically affected by advanced periodontitis. There-
fore, NGS analysis of the microbiome was performed on peri-
odontal pockets from eight such cases (BFalse Negatives^),
from six cases affected by advanced periodontitis with high
load of known pathogens at diagnosis (BPretreatment^) and
from the same six patients after successful Perioblast™ treat-
ment (BTreated^). Phylum level analysis confirmed that cases
belonging to the same subgroup have a similar community
structure and highlighted a low prevalence of known, highly
pathogenic phyla in samples in the False Negatives group as
well as in Treated samples.
OTU level analysis highlighted that bacterial species pre-
viously associated with aggressive and refractory periodontitis
[24] are, indeed, heavily reduced by the Perioblast™ protocol,
and that most of them are poorly represented in cases of the
False Negatives group. SIMPER analysis, performed at the
OTU level to identify new candidate pathogens among False
Negatives, revealed new bacterial species potentially involved
in aggressive periodontitis, some of which are abundant in
cases where the known pathogens are absent. Notably, some
of these are defined as opportunistic pathogens in various
extra-oral infections. In particular, Porphyromonas and
Prevotella species have a role in the pathogenesis of rheuma-
toid arthritis [40], while the colonisation of periodontal
pockets by Leptotrichia, Cardiobacterium, Porphyromonas,
Actinomyces and Aggregatibacter could be a precursor of en-
docarditis or atheromatous plaques [41], but also intra-
amniotic infection, neonatal infection (Leptotrichia) [42] or
septic arthritis (Actinomyces) [43].
Despite microbiological analyses being considered a po-
tentially important approach for periodontal treatments since
1991 [44], and despite periodontal microbiological tests being
available since 2000, no established guidelines exist to apply
microbiological analyses as a routine tool in the management
of periodontitis. Evaluation of the clinical results described
here should also take into account three important benefits
intrinsically associated with laser treatment. While in works
describing the outcome of standard treatment SRP is also
adopted in follow-up courses, the PERIOBLAST protocol
envisions, at follow-up, onlymaintenance laser therapy, which
is substantially less invasive and allows better preservation of
dental surfaces. Moreover, the effective and durable pocket
decontamination achieved by laser treatment, in addition to
destroying the infectivity of all microorganisms, including
viruses involved in the onset and progression of periodontitis
[45], allows reducing local and systemic antibiotic treatment
and, consequently, the risk of driving antibiotic resistance.
This is a benefit not only for the patient but also for public
health, in particular considering high-risk subjects such as
children and elderly people [46].
Finally, thanks again to its microbicidal activity, the effica-
cy of laser therapy is less dependent on the operator than
flapless SRP, whose success relies heavily on the experience
and skills of the operator. This is confirmed by the fact that
similar results were obtained in all centres applying the laser-
based protocol. Considering the above advantages, the
Perioblast™ protocol should be preferred over standard peri-
odontal treatment, even in case of comparable clinical re-
sults, to minimise invasiveness and use of antibiotics, while at
the same time achieving reproducible efficacy.
Conclusion
In the field of periodontal disease, the clinical-microbiological
study described here is unprecedented in terms of sample
numerosity and follow-up length. Our results clearly show
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that periodontal treatment driven by microbiological profiling
produces a significant improvement of all clinical parameters
and modifies the bacterial communities of periodontal
pockets, restoring an enduring healthy oral ecosystem with a
long stability, compared with the 3/6 months currently report-
ed as the maximum interval before periodontal pathogens re-
colonise the pockets [10]. Also, routine use of microbiological
assessment in a follow-up program can provide an early alert
in case of incoming relapse. According to the results of the
present study, a microbiological follow-up should be carried
out every 18/24 months, to allow for timely, quick and non-
invasive periodontal treatment, even in the most unstable
cases. Such cases, reported in the literature as ‘not good re-
sponders’ [10], could be effectively managed before the de-
velopment of new severe or irreversible tissue damages.
The results of the metagenomics analysis presented here
suggest that pathogenic bacteria not previously associated
with periodontitis could be involved in early-onset aggressive
cases. The observed efficacy of the Periodontal Biological
Laser-Assisted Therapy (Perioblast™) protocol also in such
cases suggests that the addition of laser treatment to standard
SRP could be more effective thanks to its wider bactericidal
spectrum. Additional advantages of the laser-based treatment
are reduced invasiveness at follow-up and substantial consis-
tency across operators. In conclusion, it has been shown that
periodontal treatment by neodymium-doped yttrium alumini-
um garnet (Nd:YAG) laser irradiation, guided by accurate mi-
crobiological patient characterisation, is consistently effective
in modifying oral microbiome and eradicating periodontal
pathogens, thereby restoring long-term periodontal health.
The findings described in this study are promising and
warrant further investigation through prospective randomised
clinical trials testing the efficacy of the treatment approach.
Moreover, microbiome next-generation sequencing (NGS)
analysis of larger sets of patients pre- and post-treatment is
looking to be extremely interesting. Such studies should also
explore the potential benefits for patients affected by systemic
diseases whose correlation with periodontal pathogens is sup-
ported by a steadily increasing literature.
Thanks to the deep and lasting periodontal decontamina-
tion achieved through laser therapy, the Perioblast™ protocol
allows minimising the use of antibiotics, thereby contributing
to prevent the onset of resistances by bacterial strains also
involved in systemic diseases. This benefit is particularly rel-
evant in view of the current worldwide public health efforts
aimed at optimising the use of antibiotics, according to the
World Health Organization (WHO) guidelines [47].
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